- Home
- HUN vs KYMR Comparison
HUN vs KYMR Comparison
Compare HUN & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUN
- KYMR
- Stock Information
- Founded
- HUN 1970
- KYMR 2015
- Country
- HUN United States
- KYMR United States
- Employees
- HUN N/A
- KYMR N/A
- Industry
- HUN Major Chemicals
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- HUN Industrials
- KYMR Health Care
- Exchange
- HUN Nasdaq
- KYMR Nasdaq
- Market Cap
- HUN 2.4B
- KYMR 1.8B
- IPO Year
- HUN 2005
- KYMR 2020
- Fundamental
- Price
- HUN $12.05
- KYMR $30.07
- Analyst Decision
- HUN Hold
- KYMR Buy
- Analyst Count
- HUN 9
- KYMR 13
- Target Price
- HUN $15.00
- KYMR $56.69
- AVG Volume (30 Days)
- HUN 4.2M
- KYMR 690.7K
- Earning Date
- HUN 05-01-2025
- KYMR 05-09-2025
- Dividend Yield
- HUN 8.29%
- KYMR N/A
- EPS Growth
- HUN N/A
- KYMR N/A
- EPS
- HUN N/A
- KYMR N/A
- Revenue
- HUN $5,976,000,000.00
- KYMR $58,885,000.00
- Revenue This Year
- HUN $4.09
- KYMR $16.24
- Revenue Next Year
- HUN $4.65
- KYMR $22.41
- P/E Ratio
- HUN N/A
- KYMR N/A
- Revenue Growth
- HUN 0.02
- KYMR N/A
- 52 Week Low
- HUN $11.15
- KYMR $19.45
- 52 Week High
- HUN $25.78
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- HUN 38.03
- KYMR 49.08
- Support Level
- HUN $11.15
- KYMR $28.28
- Resistance Level
- HUN $12.22
- KYMR $35.98
- Average True Range (ATR)
- HUN 0.49
- KYMR 2.26
- MACD
- HUN -0.02
- KYMR -0.10
- Stochastic Oscillator
- HUN 32.19
- KYMR 30.31
About HUN Huntsman Corporation
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.